Insiders · IRMD

Jeff Chiprin

Chief Commercial Officer at Iradimed Corp (IRMD) since November 2024

Jeff Chiprin has filed 4 insider reports with the SEC since December 2024, as chief Commercial Officer at Iradimed Corp (IRMD). The latest filing, on March 5, 2026, reports grant or award at Iradimed Corp (IRMD).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where Jeff Chiprin is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Iradimed Corp logo
IRMD
Iradimed Corp
Chief Commercial Officersince November 2024687$81.02Mar 5, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jeff Chiprin with

Other insiders at the same companies

Questions about Jeff Chiprin

What is Jeff Chiprin's role at Iradimed Corp?
Jeff Chiprin reports to the SEC as chief Commercial Officer at Iradimed Corp (IRMD), according to the latest filing on March 5, 2026.
How many shares does Jeff Chiprin own?
After the latest filing that states it, Jeff Chiprin directly owned 687 shares of Iradimed Corp (IRMD). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jeff Chiprin bought or sold stock recently?
No open-market purchases or sales by Jeff Chiprin are on file. The filings report grant or award, shares withheld for taxes or exercise price and exercise or conversion of a derivative.
How do I get alerts when Jeff Chiprin files?
Follow Jeff Chiprin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jeff Chiprin (SEC CIK 0002047489). Totals count each trade once, skipping amendments whose original is on file, from Dec 6, 2024 on. View on SEC EDGAR · Get this as JSON